[Livestock News Reporter Kim Young-gil] Seva Korea (Representative Kim Yong-seok) held a launch seminar for 'Entero-fock Coli AC' at the J1 Hotel in Cheongju, North Chungcheong, on the 16th, and announced countermeasures against piglet Escherichia coli and Clostridium. At the seminar, Jeong Byeong-yeol, advisor to the Korea Animal Pharmaceutical Evaluation Research Institute, explained, "Escherichia coli and Clostridium are the main causes of piglet diarrhea. In particular, they cause diarrhea, dehydration, necrotic enteritis, and death in newborn piglets." He added, "Vaccination of sows is necessary to increase the immunity of newborn piglets through colostrum. The vaccine has a mechanism to block Escherichia coli attachment and prevent Clostridium lesions." Cheon Du-seong, CEO of Post Bio, said, "Vaccination, hygiene management, nutrition supply, and antibiotic treatment after susceptibility testing are strategies to control Escherichia coli and Clostridium. Among these, vaccinating sows to transfer immunity to piglets is key." Veterinarian Park Sae-am from Seva Korea stated, "Despite improvements in feed management, the mortality rate due to diarrhea in newborn piglets is estimated to be 2.2%. Damage becomes greater when Escherichia coli and Clostridium are co-infected, leading to more severe clinical symptoms." He continued, "'Entero-fock Coli AC' contains Escherichia coli and Clostridium perfringens A and C antigens, including CPA α, β2 toxoid. It is a '7 in ONE' vaccine. Experimental results showed overwhelming efficacy in terms of antibody retention in colostrum and high safety in terms of reproductive performance and body temperature changes."